Picture loading failed.

Anti-PDCD1 therapeutic antibody (Pre-made Geptanolimab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Geptanolimab (also known as APL 501, CBT 501or GB 226) is an immunoglobulin G4 (IgG4) humanised ... Further details of the agreement were not disclosed.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-240-1mg 1mg 3090
GMP-Bios-ab-240-10mg 10mg 21890
GMP-Bios-ab-240-100mg 100mg 148000
GMP-Bios-ab-240-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-PDCD1 therapeutic antibody (Pre-made Geptanolimab biosimilar,Whole mAb)
INN Name Geptanolimab
TargetPDCD1
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Preregistration
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommended2021
CompaniesGenor Biopharma;Appolomics
Conditions Approvedna
Conditions ActivePeripheral T-cell lymphoma;Primary mediastinal B-cell lymphoma;Hepatocellular carcinoma
Conditions DiscontinuedLymphoma;Solid tumours
Development Techna